Browse by author
Lookup NU author(s): Dr Marion Mateos
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients’ health-related quality of life (HRQL) and its clinical/demographic correlates during treatment. Overall HRQL was significantly reduced on treatment. Despite HRQL improvements over time, longitudinal studies reported a proportion of children continued to experience reduced HRQL after treatment completion. We found inconsistent associations between clinical/demographic factors and HRQL outcomes. Tentative evidence emerged for worse HRQL being associated with intensive phases of chemotherapy, corticosteroid therapy, experiencing greater toxicity, older age, and female sex. Longitudinal studies are needed to identify children at-risk of reduced HRQL.
Author(s): Fardell JE, Vetsch J, Trahair T, Mateos MK, Grootenhuis MA, Touyz LM, Marshall GM, Wakefield CE
Publication type: Article
Publication status: Published
Journal: Pediatric Blood and Cancer
Year: 2017
Volume: 64
Issue: 9
Print publication date: 01/09/2017
Online publication date: 06/03/2017
Acceptance date: 18/01/2017
ISSN (print): 1545-5009
ISSN (electronic): 1545-5017
Publisher: Wiley
URL: https://doi.org/10.1002/pbc.26489
DOI: 10.1002/pbc.26489
Altmetrics provided by Altmetric